Please login to the form below

Incyte

J&J files ‘breakthrough’ bladder cancer drug in US

J&J could face near-term competition in the oral FGFR inhibitor category from Incyte, whose pemigatinib candidate is in phase 2 testing for bladder cancer and myeloid/lymphoid cancers, and ... Data from mid-stage studies should be available next year,

Cancer immunotherapy: What's on the horizon?

article – but, as recent experience with Incyte and Nektar Therapeutics has shown, not all new drugs and combinations will succeed. ... Meanwhile, Incyte’s Merck &Co partnered IDO inhibitor epacadostat bombed when paired with Keytruda in a melanoma

GSK sells eczema and psoriasis drug to Dermavant for £250m

s Xeljanz (tofacitinib), Incyte/Eli Lilly’s Olumiant (baricitinib) and AbbVie’s upadacitinib.

CTI slumps as Servier-partnered lymphoma drug fails

If approved, it will compete with Incyte and Novartis' Jakafi (ruxolitinib) in myelofibrosis, which is predicted to knock on the door of $1.5bn in sales this year on the back

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director or Senior Account Director: Salary TBC

Senior Writer, Healthcare Advertising, London: Excellent package

Market Access Consultant - Greater Manchester: Negotiable

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Systematic Review Lead- London: Negotiable

Account Manager: Negotiable

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Healthcare PR Senior Account Manager: Salary TBC

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Medical Writer - Creative and Scientific Projects: DOE

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Senior Account Manager – Healthcare Advertising: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Graduate Scientific Editor: DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Account Manager- 4 days per week or full-time: Salary TBC

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Senior Medical Writer: Salary is DOE

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....